Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

614.20 +14.73 (+2.46%)

Delayed Quote Updated: 11:47 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

17 18 Next >

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? ↗

May 01, 2025

Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?

Via Investor's Business Daily

Repligen (RGEN) Q1 Earnings: What To Expect

April 28, 2025

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what to look for.

Via StockStory

Topics World Trade

MEDP Q1 Earnings Call: Revenue Beats Expectations Amid Cancellations and Industry Headwinds

April 24, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance...

Via StockStory

Topics Earnings

Insights into Medpace Hldgs's Upcoming Earnings ↗

April 18, 2025

Via Benzinga

West Pharmaceutical Services Earnings: What To Look For From WST

April 23, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Wall Street Bounces Back As Traders Shake Off Powell Jabs ↗

April 22, 2025

Stocks are higher this afternoon, with all three major indexes bouncing back from Monday’s steep selloff.

Via Talk Markets

Topics Stocks / Equities

Why Medpace (MEDP) Stock Is Trading Lower Today

April 22, 2025

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 11.2% in the pre-market session after the company reported first-quarter 2025 earnings with high expectations heading into the...

Via StockStory

Medpace Hits 17-Month Low After Bookings Miss Leaves Investors Mystified ↗

April 22, 2025

The company's bookings missed expectations for the fifth consecutive quarter. Investors are questioning its "path forward."

Via Investor's Business Daily

Thermo Fisher (TMO) Reports Earnings Tomorrow: What To Expect

April 22, 2025

Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings tomorrow before the bell. Here’s what to expect.

Via StockStory

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 21, 2025

Via Benzinga

Medpace Holdings Reports Q1 Earnings, Shares Move Lower ↗

April 21, 2025

Medpace Holdings reports first-quarter financial results after the market close on Monday. Here's a look at the key metrics from the quarter.

Via Benzinga

Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops

April 21, 2025

Via StockStory

Medpace Holdings, Inc. Reports First Quarter 2025 Results

April 21, 2025

From Medpace Holdings, Inc.

Via Business Wire

Earnings Scheduled For April 21, 2025 ↗

April 21, 2025

Via Benzinga

Medpace (MEDP) Q1 Earnings: What To Expect

April 20, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market close. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

What 5 Analyst Ratings Have To Say About Medpace Hldgs ↗

April 14, 2025

Via Benzinga

1 Spectacular Growth Stock Down 34% to Buy Hand Over Fist ↗

April 05, 2025

Via The Motley Fool

Topics Initial Public Offering

3 Market-Beating Stocks with Solid Fundamentals

April 01, 2025

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...

Via StockStory

1 Healthcare Stock with Solid Fundamentals and 2 to Ignore

March 28, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

This Kraft Heinz Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗

March 24, 2025

Via Benzinga

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

March 21, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers.

Via StockStory

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

March 18, 2025

From Medpace Holdings, Inc.

Via Business Wire

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

March 18, 2025

Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.

Via StockStory

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

March 11, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...

Via StockStory

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

March 05, 2025

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

2 Reasons to Watch MEDP and 1 to Stay Cautious

March 03, 2025

Medpace has been treading water for the past six months, recording a small loss of 4.4% while holding steady at $334.43. The stock also fell short of the S&P 500’s 7.6% gain during that period.

Via StockStory

Topics Stocks

Why Medpace (MEDP) Shares Are Trading Lower Today

February 11, 2025

Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 8.7% in the pre-market session after the company reported weak fourth-quarter results: Medpace's full-year revenue, EPS, and...

Via StockStory

Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 11, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

February 10, 2025

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Medpace Stock Falls On Q4 Earnings: The Details ↗

February 10, 2025

Medpace Holdings Inc (NASDAQ:MEDP) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.